Experimental group (n = 32) | Control group (n = 34) | p-value | |
Age (years) | 28.88 ± 8.26 | 31.12 ± 11.12 | 0.518a |
Gender (female/male) | 30/2 | 32/2 | 1.000b |
Serum creatinine (mg/dl) | 1.05 ± 0.32 | 0.96 ± 0.34 | 0.472a |
eGFR (ml/min/1.73m2) | 84.19 ± 27.79 | 76.85 ± 34.90 | 0.510a |
ALT (g/L) | 42.4 ± 2.13 | 41.4 ± 2.37 | 0.081a |
24-hr UTP (gm/day) | 3.98 ± 1.88 | 3.82 ± 2.27 | 0.833a |
Anti-ds DNA (U/ml) | 116.78 ± 68.83 | 125.19 ± 68.00 | 0.726a |
Serum C3 (g/L) | 0.47 ± 0.20 | 0.49 ± 0.33 | 0.796a |
Serum C4 (g/L) | 0.14 ± 0.20 | 0.09 ± 0.07 | 0.336a |
SELENA-SLEDAI score | 18.13 ± 4.92 | 20.0 ± 3.46 | 0.213a |
Renal histology | |||
Class III | 17 (53.1%) | 14 (41.2%) | 0.331b |
Class IV | 15 (46.9%) | 20 (58.8%) |
|